COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) are used to amplify and detect the specific nucleic acid sequences of SARS-CoV-2 virus at the point-of-care.

The COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline market research report provides comprehensive information about the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report also provides information about various pipeline products and their estimated approval dates.

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, Europe, Canada, China, India, United Kingdom, Ireland, Japan, Kuwait, and Singapore. The US is the leading territory in the COVID 19 POC NAATs pipeline products market.

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Analysis by Territories, 2022 (%)

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Analysis by Territories

For more territory insights into the COVID 19 POC Nucleic Acid Amplification Tests (NAATs) pipeline products market, download a free report sample

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Segmentation by Regulatory Paths

The COVID 19 POC Nucleic Acid Amplification Tests (NAATs) pipeline report provides detailed insights into the pipeline products by regulatory path including EUA, CE-IVD, 510(k), CLIA, de novo, MDL, NMPA, and PMA. Most of the products follow the EUA pathway to enter the market.

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Analysis by Regulatory Paths, 2022 (%)

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Analysis by Regulatory Paths

For more regulatory path insights into the COVID 19 POC Nucleic Acid Amplification Tests pipeline products market, download a free report sample

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market - Competitive Landscape

Some of the leading companies in the COVID 19 Point-of-Care (POC) NAATs pipeline products market are Aegea Biotechnologies Inc, Aegis Sciences Corp, Alveo Technologies, Anavasi Diagnostics, Anitoa Systems LLC, Antigen Discovery Inc, Aptorum Group Ltd, Attoplex Co Ltd, Baebies Inc, and Bhushan J. Toley Lab.

Aegea Biotechnologies Inc: Aegea Biotechnologies Inc (Aegea) is a biotechnology company that discovers and develops reagents, research kits and in-vitro diagnostic (IVD) products for molecular analysis. The company is headquartered in San Diego, California, the US.

Aegis Sciences Corp: Aegis Sciences Corp (Aegis Sciences) operates and manages a forensic toxicology and healthcare laboratory that is engaged in offering science-driven drug testing and consulting services including urine and blood specimen testing, prenatal testing, and other testing services. The company is headquartered in Tennessee, the US.

Alveo Technologies: Alveo is a pre-clinical stage medical diagnostics company. The company is headquartered in Alameda, California, the US.

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Report Overview

Key Territories The US, Europe, Canada, China, India, United Kingdom, Ireland, Japan, Kuwait, and Singapore
Key Regulatory Paths EUA, CE-IVD, 510(k), CLIA, de novo, MDL, NMPA, and PMA
Leading Companies Aegea Biotechnologies Inc, Aegis Sciences Corp, Alveo Technologies, Anavasi Diagnostics, Anitoa Systems LLC, Antigen Discovery Inc, Aptorum Group Ltd, Attoplex Co Ltd, Baebies Inc, and Bhushan J. Toley Lab

Segments Covered in the Report

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • India
  • United Kingdom
  • Ireland
  • Japan
  • Kuwait
  • Singapore

COVID 19 POC Nucleic Acid Amplification Tests Pipeline Products Market Regulatory Paths Outlook

  • EUA
  • CE-IVD
  • 510(k)
  • CLIA
  • de novo
  • MDL
  • NMPA
  • PMA

Scope

  • Extensive coverage of the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Aegea Biotechnologies Inc
Aegis Sciences Corp
Alveo Technologies
Anavasi Diagnostics
Anitoa Systems LLC
Antigen Discovery Inc
Aptorum Group Ltd
Attoplex Co Ltd
Baebies Inc
Bhushan J. Toley Lab
Biocartis Group NV
BioLayer Corporation Limited
BiologyWorks Inc
Biyani Biosolutions Pvt Ltd
CAMPTON Diagnostics UG
CardiAI Inc
Columbia University
Columbia University Fertility Center
Coyote Bioscience Co Ltd
Credo Diagnostics Biomedical Pte Ltd
Cue Health Inc
Curiosity Diagnostics Sp zoo
DiaCarta Inc
DNA Xperts Pvt Ltd
Eurofins Scientific SE
FemtoDx Inc
Flambeau Diagnostics
Fluxergy LLC
genedrive plc
Hangzhou FasTech Biotechnology Co Ltd
Harvard University
ID Genomics Inc
Jiangsu Qitian Gene Biotechnology Co Ltd
KogeneBiotech Co Ltd
Lamprogen Inc
Lucira Health Inc
Luminex Corp
Lynntech Inc
Mammoth Biosciences Inc
McMaster University
Meridian Bioscience Inc
Merlin Biomedical (Xiamen) Co Ltd
Mesa Biotech Inc
Microgem International Plc
Midge Medica GmbH
NDFOS Co Ltd
OxDX Ltd
Patanjali Pharma Pvt Ltd
PathogenDx, Inc.
Pepex Biomedical, Inc.
Prenetics Ltd
Prime Discoveries Inc
Princeton University
Prominex Inc
QuikPath Pte Ltd
RNA Disease Diagnostics Inc
Sense Biodetection Ltd
Sentebiolab Biotechnology
Shenzhen Second People's Hospital
Shimadzu Corp
Shionogi & Co Ltd
Tangen Biosciences Inc
Todos Medical
Uh-OH Labs Inc
University of California Berkeley
University of Illinois at Urbana-Champaign
University of Texas Southwestern Medical Center
Veredus Laboratories Pte Ltd
Visby Medical Inc
XP Diagnostics GmbH

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Overview

  • 3 Products under Development

    • 3.1 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development
    • 3.2 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory
    • 3.3 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path
    • 3.4 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Estimated Approval Date
    • 3.5 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials

  • 4 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products under Development by Companies

    • 4.1 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Companies – Pipeline Products by Stage of Development
    • 4.2 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development

  • 5 COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Companies and Product Overview

    • 5.1 Aegea Biotechnologies Inc Company Overview

      • 5.1.1 Aegea Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Aegis Sciences Corp Company Overview

      • 5.2.1 Aegis Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Alveo Technologies Company Overview

      • 5.3.1 Alveo Technologies Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Anavasi Diagnostics Company Overview

      • 5.4.1 Anavasi Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Anitoa Systems LLC Company Overview

      • 5.5.1 Anitoa Systems LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Antigen Discovery Inc Company Overview

      • 5.6.1 Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Aptorum Group Ltd Company Overview

      • 5.7.1 Aptorum Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Attoplex Co Ltd Company Overview

      • 5.8.1 Attoplex Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Baebies Inc Company Overview

      • 5.9.1 Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Bhushan J. Toley Lab Company Overview

      • 5.10.1 Bhushan J. Toley Lab Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Biocartis Group NV Company Overview

      • 5.11.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 BioLayer Corporation Limited Company Overview

      • 5.12.1 BioLayer Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 BiologyWorks Inc Company Overview

      • 5.13.1 BiologyWorks Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Biyani Biosolutions Pvt Ltd Company Overview

      • 5.14.1 Biyani Biosolutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 CAMPTON Diagnostics UG Company Overview

      • 5.15.1 CAMPTON Diagnostics UG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 CardiAI Inc Company Overview

      • 5.16.1 CardiAI Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Columbia University Company Overview

      • 5.17.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Columbia University Fertility Center Company Overview

      • 5.18.1 Columbia University Fertility Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Coyote Bioscience Co Ltd Company Overview

      • 5.19.1 Coyote Bioscience Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Credo Diagnostics Biomedical Pte Ltd Company Overview

      • 5.20.1 Credo Diagnostics Biomedical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Cue Health Inc Company Overview

      • 5.21.1 Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Curiosity Diagnostics Sp zoo Company Overview

      • 5.22.1 Curiosity Diagnostics Sp zoo Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 DiaCarta Inc Company Overview

      • 5.23.1 DiaCarta Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 DNA Xperts Pvt Ltd Company Overview

      • 5.24.1 DNA Xperts Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Eurofins Scientific SE Company Overview

      • 5.25.1 Eurofins Scientific SE Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 FemtoDx Inc Company Overview

      • 5.26.1 FemtoDx Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Flambeau Diagnostics Company Overview

      • 5.27.1 Flambeau Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 Fluxergy LLC Company Overview

      • 5.28.1 Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 genedrive plc Company Overview

      • 5.29.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 Hangzhou FasTech Biotechnology Co Ltd Company Overview

      • 5.30.1 Hangzhou FasTech Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 Harvard University Company Overview

      • 5.31.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 ID Genomics Inc Company Overview

      • 5.32.1 ID Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.33 Jiangsu Qitian Gene Biotechnology Co Ltd Company Overview

      • 5.33.1 Jiangsu Qitian Gene Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.34 KogeneBiotech Co Ltd Company Overview

      • 5.34.1 KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.35 Lamprogen Inc Company Overview

      • 5.35.1 Lamprogen Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.36 Lucira Health Inc Company Overview

      • 5.36.1 Lucira Health Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.37 Luminex Corp Company Overview

      • 5.37.1 Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.38 Lynntech Inc Company Overview

      • 5.38.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.39 Mammoth Biosciences Inc Company Overview

      • 5.39.1 Mammoth Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.40 McMaster University Company Overview

      • 5.40.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.41 Meridian Bioscience Inc Company Overview

      • 5.41.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.42 Merlin Biomedical (Xiamen) Co Ltd Company Overview

      • 5.42.1 Merlin Biomedical (Xiamen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.43 Mesa Biotech Inc Company Overview

      • 5.43.1 Mesa Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.44 Microgem International Plc Company Overview

      • 5.44.1 Microgem International Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.45 Midge Medica GmbH Company Overview

      • 5.45.1 Midge Medica GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.46 NDFOS Co Ltd Company Overview

      • 5.46.1 NDFOS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.47 OxDX Ltd Company Overview

      • 5.47.1 OxDX Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.48 Patanjali Pharma Pvt Ltd Company Overview

      • 5.48.1 Patanjali Pharma Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.49 PathogenDx, Inc. Company Overview

      • 5.49.1 PathogenDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.50 Pepex Biomedical, Inc. Company Overview

      • 5.50.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.51 Prenetics Ltd Company Overview

      • 5.51.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.52 Prime Discoveries Inc Company Overview

      • 5.52.1 Prime Discoveries Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.53 Princeton University Company Overview

      • 5.53.1 Princeton University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.54 Prominex Inc Company Overview

      • 5.54.1 Prominex Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.55 QuikPath Pte Ltd Company Overview

      • 5.55.1 QuikPath Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.56 RNA Disease Diagnostics Inc Company Overview

      • 5.56.1 RNA Disease Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.57 Sense Biodetection Ltd Company Overview

      • 5.57.1 Sense Biodetection Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.58 Sentebiolab Biotechnology Company Overview

      • 5.58.1 Sentebiolab Biotechnology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.59 Shenzhen Second People’s Hospital Company Overview

      • 5.59.1 Shenzhen Second People’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

    • 5.60 Shimadzu Corp Company Overview

      • 5.60.1 Shimadzu Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.61 Shionogi & Co Ltd Company Overview

      • 5.61.1 Shionogi & Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.62 Tangen Biosciences Inc Company Overview

      • 5.62.1 Tangen Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.63 Todos Medical Company Overview

      • 5.63.1 Todos Medical Pipeline Products & Ongoing Clinical Trials Overview

    • 5.64 Uh-OH Labs Inc Company Overview

      • 5.64.1 Uh-OH Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.65 University of California Berkeley Company Overview

      • 5.65.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview

    • 5.66 University of Illinois at Urbana-Champaign Company Overview

      • 5.66.1 University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview

    • 5.67 University of Texas Southwestern Medical Center Company Overview

      • 5.67.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.68 Veredus Laboratories Pte Ltd Company Overview

      • 5.68.1 Veredus Laboratories Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.69 Visby Medical Inc Company Overview

      • 5.69.1 Visby Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.70 XP Diagnostics GmbH Company Overview

      • 5.70.1 XP Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Appendix

    • 6.1 Methodology
    • 6.2 About GlobalData
    • 6.3 Contact Us
    • 6.4 Disclaimer

Table

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 13

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory 14

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path 15

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Estimated Approval Date 16

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials 17

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Companies – Pipeline Products by Stage of Development 18

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 21

Aegea Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 23

SARS-CoV-2 Test – Product Status 23

SARS-CoV-2 Test – Product Description 23

Aegis Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Nucleic Acid Detection Kit – SARS-CoV-2 – Product Status 24

Nucleic Acid Detection Kit – SARS-CoV-2 – Product Description 24

Alveo Technologies Pipeline Products & Ongoing Clinical Trials Overview 25

be.well Multiplex Assay – Product Status 25

be.well Multiplex Assay – Product Description 25

Anavasi Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 26

AscencioDx – Product Status 26

AscencioDx – Product Description 26

RT-LAMP Test – COVID/Flu – Product Status 27

RT-LAMP Test – COVID/Flu – Product Description 27

Anavasi Diagnostics – Ongoing Clinical Trials Overview 28

AscencioDx – POC Sars-Cov-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test 29

Anitoa Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Ultra-Rapid Real-time RT-PCR Assay – COVID-19 – Product Status 30

Ultra-Rapid Real-time RT-PCR Assay – COVID-19 – Product Description 30

Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 31

POC Test – COVID-19/Influenza – Product Status 31

POC Test – COVID-19/Influenza – Product Description 31

Aptorum Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

RPIDD – Product Status 32

RPIDD – Product Description 33

Aptorum Group Ltd – Ongoing Clinical Trials Overview 34

RPIDD – Clinical Validation Study of Rapid Pathogen Identification and Detection Diagnostics Technology (RPIDD) for Diagnosis of Infectious Diseases 35

Attoplex Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Rapid Gene Amplification Home Test – COVID-19 – Product Status 36

Rapid Gene Amplification Home Test – COVID-19 – Product Description 36

Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Diagnostic Panel – COVID-19 And Common Respiratory Infections – Product Status 37

Diagnostic Panel – COVID-19 And Common Respiratory Infections – Product Description 37

FINDER SARS-CoV-2 Test – Product Status 38

FINDER SARS-CoV-2 Test – Product Description 38

Bhushan J. Toley Lab Pipeline Products & Ongoing Clinical Trials Overview 39

Paper-Based SARS-CoV-2 Diagnostic Kit – Product Status 39

Paper-Based SARS-CoV-2 Diagnostic Kit – Product Description 39

Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 40

Idylla SARS-CoV-2 Test – Product Status 40

Idylla SARS-CoV-2 Test – Product Description 40

BioLayer Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview 41

COVID-19 Antigen Flu A Flu B Multiplex RDT – Product Status 41

COVID-19 Antigen Flu A Flu B Multiplex RDT – Product Description 42

BiologyWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 43

BiologyWorks k(now) Test – Product Status 43

BiologyWorks k(now) Test – Product Description 44

Biyani Biosolutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Self-Swab RNA Test – COVID-19 – Product Status 45

Self-Swab RNA Test – COVID-19 – Product Description 45

CAMPTON Diagnostics UG Pipeline Products & Ongoing Clinical Trials Overview 46

CAMPTON COVID-19 RT-LAMP Test – Product Status 46

CAMPTON COVID-19 RT-LAMP Test – Product Description 46

CardiAI Inc Pipeline Products & Ongoing Clinical Trials Overview 47

CoviLamp – PCR Test – Product Status 47

CoviLamp – PCR Test – Product Description 47

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 48

Molecular SARS-CoV-2 Diagnostic Test – Product Status 48

Molecular SARS-CoV-2 Diagnostic Test – Product Description 48

Columbia University Fertility Center Pipeline Products & Ongoing Clinical Trials Overview 49

COVID-19 Saliva Test – Product Status 49

COVID-19 Saliva Test – Product Description 49

Coyote Bioscience Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

nCoV Prep Free QPCR Assay – Product Status 50

nCoV Prep Free QPCR Assay – Product Description 50

Credo Diagnostics Biomedical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

VitaPCR SARS-CoV-2 Gen 2 Assay – Product Status 51

VitaPCR SARS-CoV-2 Gen 2 Assay – Product Description 51

Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Cue COVID-19 Test – Home Use – Product Status 52

Cue COVID-19 Test – Home Use – Product Description 52

Curiosity Diagnostics Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 53

PCR|ONE – Respiratory Panel – Product Status 53

PCR|ONE – Respiratory Panel – Product Description 53

PCR|ONE System – SARS-CoV-2 Panel – Product Status 54

PCR|ONE System – SARS-CoV-2 Panel – Product Description 54

DiaCarta Inc Pipeline Products & Ongoing Clinical Trials Overview 55

QuantiVirus SARS-CoV-2 Variant Detection Test – Product Status 55

QuantiVirus SARS-CoV-2 Variant Detection Test – Product Description 55

DNA Xperts Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

COVID-19 RT-PCR Kit – V2 – Product Status 56

COVID-19 RT-PCR Kit – V2 – Product Description 56

Eurofins Scientific SE Pipeline Products & Ongoing Clinical Trials Overview 57

GSD NovaType III SARS-CoV-2 RT-PCR – Product Status 57

GSD NovaType III SARS-CoV-2 RT-PCR – Product Description 57

FemtoDx Inc Pipeline Products & Ongoing Clinical Trials Overview 58

COVID-19 Rapid Home Nucleic Acid Test – Product Status 58

COVID-19 Rapid Home Nucleic Acid Test – Product Description 58

Flambeau Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 59

RT-Lamp Test – COVID-19 – Product Status 59

RT-Lamp Test – COVID-19 – Product Description 59

Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Flu/RSV/SARS-CoV-2 PCR Panel – Product Status 60

Flu/RSV/SARS-CoV-2 PCR Panel – Product Description 60

genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 61

Genedrive SARS-CoV-2 POC Kit – Version 2 – Product Status 61

Genedrive SARS-CoV-2 POC Kit – Version 2 – Product Description 61

Hangzhou FasTech Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Nucleic Acid Rapid Detection Kit – COVID-19 – Product Status 62

Nucleic Acid Rapid Detection Kit – COVID-19 – Product Description 62

Harvard University Pipeline Products & Ongoing Clinical Trials Overview 63

COVID-19 POC Detection Assay – Product Status 63

COVID-19 POC Detection Assay – Product Description 63

ID Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Gene Fingerprinting Rapid Test – COVID-19 – Product Status 64

Gene Fingerprinting Rapid Test – COVID-19 – Product Description 64

Jiangsu Qitian Gene Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

SARS-CoV-2 Nucleic Acid Detection Kit – Product Status 65

SARS-CoV-2 Nucleic Acid Detection Kit – Product Description 65

KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Kogene Variant Kit – Product Status 66

Kogene Variant Kit – Product Description 66

Lamprogen Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Pdot- Enabled Digital PCR Assay – Product Status 67

Pdot- Enabled Digital PCR Assay – Product Description 67

Lucira Health Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Lucira COVID-19 & Flu Test – Home Use – Product Status 68

Lucira COVID-19 & Flu Test – Home Use – Product Description 68

Lucira COVID-19 & Flu Test – Professional Use – Product Status 69

Lucira COVID-19 & Flu Test – Professional Use – Product Description 69

Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 70

Verigene I Acute Dx – COVID-19 – Product Status 70

Verigene I Acute Dx – COVID-19 – Product Description 70

VERIGENE I SARS-CoV-2 – Product Status 71

VERIGENE I SARS-CoV-2 – Product Description 71

Verigene II Acute Dx – COVID-19 – Product Status 71

Verigene II Acute Dx – COVID-19 – Product Description 72

VERIGENE II SARS-CoV-2 – Product Status 72

VERIGENE II SARS-CoV-2 – Product Description 72

Verigene II Syndromic Dx – COVID-19 – Product Status 73

Verigene II Syndromic Dx – COVID-19 – Product Description 73

Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 74

At-Home POC Assay – SARS-CoV-2 – Product Status 74

At-Home POC Assay – SARS-CoV-2 – Product Description 74

Mammoth Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 75

CRISPR Based DETECTR COVID-19 Test – OTC – Product Status 75

CRISPR Based DETECTR COVID-19 Test – OTC – Product Description 75

McMaster University Pipeline Products & Ongoing Clinical Trials Overview 76

Self-Diagnosis Kit – COVID-19 – Product Status 76

Self-Diagnosis Kit – COVID-19 – Product Description 76

Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Rapid Acute Respiratory Viral Panel Assay – Product Status 77

Rapid Acute Respiratory Viral Panel Assay – Product Description 78

Merlin Biomedical (Xiamen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Novel Coronavirus (COVID-19) RT-PCR Kit – Product Status 79

Novel Coronavirus (COVID-19) RT-PCR Kit – Product Description 79

Mesa Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Accula SARS-CoV-2/Flu A/Flu B Combination Test – Product Status 80

Accula SARS-CoV-2/Flu A/Flu B Combination Test – Product Description 80

Microgem International Plc Pipeline Products & Ongoing Clinical Trials Overview 81

MicroGEM Sal6830 SARS-CoV-2 Saliva Test – Product Status 81

MicroGEM Sal6830 SARS-CoV-2 Saliva Test – Product Description 81

Midge Medica GmbH Pipeline Products & Ongoing Clinical Trials Overview 82

Corona Self-Test – Product Status 82

Corona Self-Test – Product Description 82

NDFOS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

ND COVID-19/Flu Combo Kit – Product Status 83

ND COVID-19/Flu Combo Kit – Product Description 83

OxDX Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

AI Based Rapid Diagnostic Test – Infectious Diseases – Product Status 84

AI Based Rapid Diagnostic Test – Infectious Diseases – Product Description 84

Patanjali Pharma Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

CRISPR Based COVID-19 Test – Product Status 85

CRISPR Based COVID-19 Test – Product Description 85

PathogenDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

DetectX-Cv – Product Status 86

DetectX-Cv – Product Description 86

Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87

COVID-19 Antigen Detection Test – Product Status 87

COVID-19 Antigen Detection Test – Product Description 87

Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

Circle HealthPod – Product Status 88

Circle HealthPod – Product Description 89

OX-LAMP – Product Status 89

OX-LAMP – Product Description 89

Prime Discoveries Inc Pipeline Products & Ongoing Clinical Trials Overview 90

CovidDetect – Product Status 90

CovidDetect – Product Description 90

Princeton University Pipeline Products & Ongoing Clinical Trials Overview 91

SHINEv.2 At-Home Diagnostic Test – Product Status 91

SHINEv.2 At-Home Diagnostic Test – Product Description 91

SHINEv.2 Diagnostic Test – Product Status 92

SHINEv.2 Diagnostic Test – Product Description 92

Prominex Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Validex System – Flu/RSV/SARS-CoV-2 Assay – Product Status 93

Validex System – Flu/RSV/SARS-CoV-2 Assay – Product Description 93

Validex System – SARS-CoV-2 Test – Product Status 94

Validex System – SARS-CoV-2 Test – Product Description 94

QuikPath Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

QuikPath SARS-CoV-2 Isothermal RT-PCR Kit – Product Status 95

QuikPath SARS-CoV-2 Isothermal RT-PCR Kit – Product Description 95

RNA Disease Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 96

Antisense Molecular Point Of Care (POC) Diagnostic Test Kit – Product Status 96

Antisense Molecular Point Of Care (POC) Diagnostic Test Kit – Product Description 96

Sense Biodetection Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

Veros COVID-19 Molecular Test – Product Status 97

Veros COVID-19 Molecular Test – Product Description 97

Sentebiolab Biotechnology Pipeline Products & Ongoing Clinical Trials Overview 98

Senteligo Covid-19 qRT PCR Detection Kit – Product Status 98

Senteligo Covid-19 qRT PCR Detection Kit – Product Description 98

Shenzhen Second People’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 99

Nucleic Acid Assay – COVID-19 – Product Status 99

Nucleic Acid Assay – COVID-19 – Product Description 99

Shenzhen Second People’s Hospital – Ongoing Clinical Trials Overview 100

Nucleic Acid Assay – COVID-19 – Development and Application of a Novel High Sensitivity Nucleic Acid Assay for Novel Coronavirus Pneumonia (COVID-19) Based on CRISPR-cas Protein 101

Shimadzu Corp Pipeline Products & Ongoing Clinical Trials Overview 102

Ampdirect 2019-nCoV Detection Kit – Product Status 102

Ampdirect 2019-nCoV Detection Kit – Product Description 102

Shionogi & Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 103

SATIC Diagnostic Test – Product Status 103

SATIC Diagnostic Test – Product Description 103

Tangen Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 104

Flu/RSV/COVID-19 Panel – Product Status 104

Flu/RSV/COVID-19 Panel – Product Description 104

Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 105

Todos 2019-nCoV RT-qPCR Detection Kit – Product Status 105

Todos 2019-nCoV RT-qPCR Detection Kit – Product Description 105

Uh-OH Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 106

UOL COVID-19 Test – Over The Counter Use – Product Status 106

UOL COVID-19 Test – Over The Counter Use – Product Description 106

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 107

Point-Of-Care Diagnostic Test – COVID-19 – Product Status 107

Point-Of-Care Diagnostic Test – COVID-19 – Product Description 107

University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview 108

Diagnostic Home Test – COVID-19 – Product Status 108

Diagnostic Home Test – COVID-19 – Product Description 108

University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 109

CoVarScan – Product Status 109

CoVarScan – Product Description 109

Veredus Laboratories Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

VereRTCoV 3.0 ZeroStep Real-Time RT-PCR – Product Status 110

VereRTCoV 3.0 ZeroStep Real-Time RT-PCR – Product Description 110

Visby Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 111

Flu-COVID PCR Test – Product Status 111

Flu-COVID PCR Test – Product Description 111

XP Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

COVID-19 PCR Diagnostic Kit – Product Status 112

COVID-19 PCR Diagnostic Kit – Product Description 112

Glossary 115

Figures

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 13

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory 14

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path 15

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Estimated Approval Date 16

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials 17

Frequently asked questions

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.